Clinical trial
New Onset Type 1 Diabetes: Role of Exenatide
NCT01269034 is registered in ClinicalTrials.gov with Albert Einstein College of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- New Onset Type 1 Diabetes: Role of Exenatide
- Lead sponsor
- Albert Einstein College of Medicine
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 31, 2010
- Completion date
- January 31, 2017
- Enrollment
- 13 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
type 1 diabetes